Corcept Therapeutics | CORT - 销售成本



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 11.4B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


销售成本 更改 日
Acadia Pharmaceuticals USD 28.32M 3.52M 2026-06
Alaunos Therapeutics USD 0 18K 2024-09
ANI Pharmaceuticals USD 119.8M 5.3M 2026-06
Ardelyx USD 4.81M 6.04M 2026-03
Aurora Cannabis CAD 8.22M 80.38M 2026-03
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Canopy Growth CAD 62.98M 9.91M 2026-03
Corcept Therapeutics USD 4.06M 1.18M 2026-06
Eli Lilly USD 3.27B 309M 2026-06
J&J USD 8B 67M 2026-06
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Merck USD 3.14B 200M 2026-06
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novartis USD 3.71B 251M 2026-06
Novartis USD 3.46B 83M 2026-03
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 58.49M 7.75M 2026-06
Pfizer USD 4.09B 498M 2026-06
Supernus Pharmaceuticals USD 59M 9.97M 2026-06
TG Therapeutics USD 41.19M 7.68M 2026-06